Cochrane Review Group
Musculoskeletal
143 systematic reviews in Musculoskeletal ask 1,956 questions. 28.4% have no studies to answer them, 13% rest on very low certainty evidence and 24.8% reach moderate or high certainty.
Reviews
143
Questions
1,956
current versions
No studies
28.4%
Moderate or high
24.8%
No studies 555 · 28.4%Ungraded 107 · 5.5%Very low 255 · 13%Low 555 · 28.4%Moderate 357 · 18.3%High 127 · 6.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Methotrexate vs placebo Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Treatment responsea · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Function · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Pain · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Participant global assessment of well‐being · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Serious adverse events(12 months) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | Very low |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Sustained clinically inactive diseasec · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs alternative disease‐modifying antirheumatic drugs Pain · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Sustained clinically inactive diseasec · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Methotrexate vs placebo Function · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Oral methotrexate plus intra‐articular glucocorticoid vs intra‐articular glucocorticoid alone Outcomes(time frame of absolute effects) · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane | no estimate extracted | NR | No studies |
Reviews 143
Vitamin D supplementation for improving bone mineral density in children
CochraneSoF table
5 questions
Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement
CochraneSoF table
6 questions
Joint lavage for osteoarthritis of the knee
CochraneSoF table
7 questions
Balance training (proprioceptive training) for patients with rheumatoid arthritis
CochraneSoF table
7 questions
Interventions for treating osteoarthritis of the big toe joint
CochraneSoF table
3 questions
Surgery for shoulder osteoarthritis
CochraneSoF table
6 questions
Botulinum toxin for shoulder pain
CochraneSoF table
5 questions
Tocilizumab for rheumatoid arthritis
CochraneSoF table
7 questions
Golimumab for rheumatoid arthritis
CochraneSoF table
7 questions
Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis
CochraneSoF table
7 questions
Transcutaneous electrostimulation for osteoarthritis of the knee
CochraneSoF table
5 questions
Topical glyceryl trinitrate for rotator cuff disease
CochraneSoF table
19 questions
Assistive technology for rheumatoid arthritis
CochraneSoF table
7 questions
Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis
CochraneSoF table
23 questions
Abatacept for rheumatoid arthritis
CochraneSoF table
7 questions
S‐Adenosylmethionine for osteoarthritis of the knee or hip
CochraneSoF table
5 questions
Glucosamine therapy for treating osteoarthritis
CochraneSoF table
9 questions
Leflunomide for the treatment of rheumatoid arthritis
CochraneSoF table
11 questions